DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

MANGCHEFER vs SUDARSHAN: Stock Comparison

MANGCHEFER vs SUDARSHAN PHARMA INDUpdated 30 Oct 25, 4:01 PM ISTNSE & company filings

MANGCHEFER shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

MANGCHEFER leads 4; SUDARSHAN leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

MANGCHEFERSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹0 Cr
₹0 Cr
P/E RatioMANGCHEFER has the lower reading
0x ✓
28.27x
P/B RatioMANGCHEFER has the lower reading
0x ✓
4.11x
EPSMANGCHEFER has the higher reading
₹5.2 ✓
₹0.32
Book ValueContext only
₹89.84
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
MANGCHEFER has a lower P/E
0x vs 28.27x
P/B Ratio
MANGCHEFER has a lower P/B
0x vs 4.11x
EPS
MANGCHEFER has higher earnings per share
₹5.2 vs ₹0.32
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs 0%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs 0%
Net Margin
MANGCHEFER has a higher net margin
4.31% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMANGCHEFERSUDARSHAN
SectorChemicals—
IndustryFertilizers—

Price

MetricMANGCHEFERSUDARSHAN
Live Price₹308.75₹32.71
Day Change-0.42%0.03%
Volume4.71 L92,985
52-Week High₹310.75₹39.3
52-Week Low₹300.25₹31.01
Distance from 52W High-0.64%-16.77%

Valuation

MetricMANGCHEFERSUDARSHAN
Market Cap₹0 Cr₹0 Cr
P/E Ratio0x28.27x
P/B Ratio0x4.11x
EPS₹5.2₹0.32
Book Value₹89.84₹6.14
Dividend Yield0%0%

Growth

MetricMANGCHEFERSUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%24.4%
Qtr Profit Growth0%38.7%

Profitability & Leverage

MetricMANGCHEFERSUDARSHAN
ROE15.16%—
ROCE12.32%—
Net Margin4.31%0%
Operating Margin8.55%—
Debt to Equity0.7x—

Shareholding

As of Sep 2025 • change vs previous quarter
MetricMANGCHEFERSUDARSHAN
Promoter Holding59.44%57.81%▼ 1.12 pp
FII Holding3.01%▼ 0.08 pp21.95%▲ 2.57 pp
DII Holding8.6%▲ 2.13 pp0%
Public Holding26.88%▼ 2.04 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MANGCHEFER and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.